SCHEMBL25106906

SCHEMBL25106906

CCc1cccc(N2CCN(C)CC2)c1CC

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.69
DRD3 P35462 6/20 0.69
HTR1A P08908 4/20 0.69
DRD4 P21917 3/20 0.69
HTR2A P28223 3/20 0.69
HTR2C P28335 3/20 0.69
BRD9 Q9H8M2 3/20 0.51
BRD4 O60885 1/20 0.51
BRPF1 P55201 1/20 0.51
NCF1 P14598 1/20 0.50
ADRA2C P18825 1/20 0.47
EGFR P00533 1/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
KMT2A Q03164 1/20 0.46
HTR1D P28221 1/20 0.41
HTR1B P28222 1/20 0.41
BRD7 Q9NPI1 1/20 0.41
HTR6 P50406 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8361520 0.85 DRD2 (0.72) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL28845229 0.84 HTR1A (0.49) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24683684 0.81 DRD2 (1.00) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL25106971 0.81 DRD2 (0.65) DRD2DRD3HTR1ADRD4HTR2A
Hydrochloric Acid SCHEMBL11552605 0.80 HTR1A (0.68) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL10424519 0.77 HTR1A (0.59) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL22169146 0.77 DRD2 (0.49) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL19561871 0.76 CHRNA7 (0.49) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL25106668 0.75 DRD2 (0.48) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL11557911 0.75 LMNA (0.50) DRD2DRD3HTR1ADRD4HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230076435-A1 MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) 2023-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230076435-A1 MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF GRM4, GRM5, GRIA4 DRD2 343/4885DRD3 367/4885HTR1A 75/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.